[1] Kraja B, Mone I, Akshija I, et al. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients[J]. World J Gastroenterol, 2017,23(26): 4806-4814. [2] Lesmana C, Raharjo M, Gani R A. Managing liver cirrhotic complications: overview of esophageal and gastric varices[J]. Clin Mol Hepatol, 2020,26(4): 444-460. [3] Garcia-Tsao G, Abraldes J G, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017,65(1): 310-335. [4] Magaz M, Baiges A, Hernandez-Gea V. Precision medicine in variceal bleeding: are we there yet?[J]. J Hepatol, 2020,72(4): 774-784. [5] Collins G S, Reitsma J B, Altman D G, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement[J]. BMJ, 2015,350: g7594. [6] Moons K G, Hooft L, Williams K, et al. Implementing systematic reviews of prognosis studies in Cochrane[J]. Cochrane Database Syst Rev, 2018,10(10): ED129. [7] Moons K G, de Groot J A, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist[J]. PLoS Med, 2014,11(10): e1001744. [8] Moons K, Wolff R F, Riley R D, et al. PROBAST: A tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration[J]. Ann Intern Med, 2019,170(1): W1-W33. [9] Ma J L, He L L, Jiang Y, et al. New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease[J]. Ann Hepatol, 2020,19(3): 287-294. [10] Huo Y, Yu H, Zhang Q, et al. Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients[J]. Diagn Pathol, 2023,18(1): 29. [11] Luo R, Gao J, Gan W, et al. Clinical-radiomics nomogram for predicting esophagogastric variceal bleeding risk noninvasively in patients with cirrhosis[J]. World J Gastroenterol, 2023,29(6): 1076-1089. [12] Agarwal S, Sharma S, Kumar M, et al. Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: a proof of concept[J]. J Gastroenterol Hepatol, 2021,36(10): 2935-2942. [13] 白雪, 刘晓艳, 杜文军, 等. 肝硬化合并食管胃底静脉曲张患者发生破裂出血的危险因素分析[J]. 安徽医科大学学报, 2024,59(1): 149-153. [14] 张争运, 杨梅, 刘百庆, 等. 肝硬化患者食管胃底静脉曲张无创预测模型的构建及验证[J]. 重庆医学, 2021,50(21): 3669-3673. [15] 李晓娟, 徐鑫鑫, 方青青, 等. 肝硬化食管胃静脉曲张发生的影响因素分析及列线图预测模型构建[J]. 中国医师杂志, 2024(4): 503-508. [16] 门昌君, 张国梁, 邵娴. 基于超声内镜及临床数据预测肝硬化患者出血风险的列线图模型建立[J]. 中华肝脏病杂志, 2021(8): 759-765. [17] 王群茹, 周德江, 曾维政, 等. 建立肝硬化食管胃底静脉曲张破裂的多因素出血概率风险预测模型[J]. 西部医学, 2018,30(7): 993-997. [18] 秦相清, 朱陈, 张海银. 构建诺模图模型预测肝硬化食管胃底静脉曲张出血的风险[J]. 中华消化病与影像杂志(电子版), 2024,14(4): 330-335. [19] 郭茂东, 胡亮, 陈燕萍, 等. 肝硬化患者高危食管静脉曲张列线图预测模型的构建研究[J]. 中国全科医学, 2021,24(30): 3848-3855. [20] 张静, 吴丹丹, 强丽, 等. 肝硬化患者首次静脉曲张破裂出血列线图预测模型的构建及验证[J]. 四川医学, 2023,44(4): 372-379. [21] Zanetto A, Campello E, Senzolo M, et al. The evolving knowledge on primary hemostasis in patients with cirrhosis: a comprehensive review[J]. Hepatology, 2024,79(2): 460-481. [22] Cifci S, Ekmen N. Evaluation of non-invasive fibrosis markers in predicting esophageal variceal bleeding[J]. Clin Endosc, 2021,54(6): 857-863. [23] Adami M R, Kieling C O, Schwengber F P, et al. Noninvasive methods of predicting large esophageal varices in children with intrahepatic portal hypertension[J]. J Pediatr Gastroenterol Nutr, 2018,66(3): 442-446. [24] 倪猛, 张海洋. 内镜下套扎联合硬化剂注射治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者疗效及其再出血危险因素分析[J]. 实用肝脏病杂志, 2018,21(2):241-244. [25] 钟熹, 方伟军, 麦慧, 等. 常规T2WI序列纹理分析鉴别肝硬化背景的小肝癌和增生结节的价值[J]. 临床放射学杂志, 2019,38(3): 448-451. [26] 徐小元, 丁惠国, 令狐恩强, 等. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2023,39(3): 527-538. [27] Kothari H G, Gupta S J, Gaikwad N R, et al. Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India[J]. Turk J Gastroenterol, 2019,30(12): 1036-1043. [28] Marot A, Trepo E, Doerig C, et al. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding[J]. Liver International, 2017,37(5): 707-716. [29] Singh V, De A, Mehtani R, et al. Asia-Pacific association for study of liver guidelines on management of ascites in liver disease[J]. Hepatol Int, 2023,17(4): 792-826. [30] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 中华肝脏病杂志, 2017(9): 664-677. [31] 揭方荣, 郑嵘炅, 邓泽润, 等. 肝硬化失代偿期患者食管胃底静脉曲张破裂再出血的危险因素分析[J]. 肝脏, 2017,22(8): 729-732. [32] 刘泰铭, 张新晨. 胆囊结石合并肝硬化门静脉高压症的发病机制研究及外科治疗[J]. 中国医师进修杂志, 2017,40(6): 568-570. [33] 黄登, 曹君贵, 叶航羊, 等. 肝硬化门静脉高压血流动力学紊乱发生及发展机制[J]. 中华消化外科杂志, 2021(10): 1117-1122. [34] 杨连粤, 白雪莉. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J]. 中国实用外科杂志, 2019,39(12): 1241-1247. |